𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Effusion cytology of metastatic extraskeletal myxoid chondrosarcoma

✍ Scribed by Karl T.K. Chen


Publisher
John Wiley and Sons
Year
2003
Tongue
English
Weight
77 KB
Volume
28
Category
Article
ISSN
8755-1039

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Extraskeletal myxoid chondrosarcoma : A
✍ Satoshi Kawaguchi; Takuro Wada; Satoshi Nagoya; Tatsuru Ikeda; Kazuo Isu; Katsus πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 108 KB

## Abstract ## BACKGROUND Extraskeletal myxoid chondrosarcoma (EMC) is a rare malignant neoplasm. Despite a consensus for the distinct clinicopathologic entity of EMC, its clinical features remain controversial. In addition, most studies have contained a small number of patients who underwent defi

TFG is a novel fusion partner of NOR1 in
✍ Masanori Hisaoka; Tsuyoshi Ishida; Tetsuo Imamura; Hiroshi Hashimoto πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 138 KB

## Abstract Extraskeletal myxoid chondrosarcoma (EMC) is characterized by recurrent chromosomal translocations resulting in fusions of the nuclear receptor gene __NOR1__ (also known as __CHN__ or __TEC__) to various N‐terminal partners, including __EWS__ and __TAF2N__ (or __RBP56__). Significant st

Extraskeletal myxoid chondrosarcoma. A c
✍ George Saleh; Harry L. Evans; Jae Y. Ro; Alberto G. Ayala πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 English βš– 517 KB

Extraskeletal myxoid chondrosarcoma (EMC) is a rare soft tissue sarcoma that has been reported to have a relatively good prognosis. The authors report ten patients with EMC on whom there was a minimum follow-up of 10 years. The patients' ages ranged from 31 to 72 years (mean, 57 years); there were s